Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
S. Purohit Joshi (Jaipur, India), A. Sinha (Hyderabad, India), H. Mishra (Jaipur, India), P. Rijhwani (Jaipur, India), R. Sarkar (Kent, United Kingdom), P. Sekhar Das (Bangalore, India), S. Jana (Hyderabad, India). Assessment of the role of CT severity score in COVID-19 outcome prediction in a large Indian cohort. 933

Member's Comments

No comment yet.

Related content which might interest you: Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Development and pilot testing of a new 7-item cough severity patient reported outcome measure Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Assessment of the probability of lung cancer diagnosis using authorial predictive scale. Pilot study. Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Performance scores in patients with suspected lung cancer: reliability of scoring and impact on treatment Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Influence of antibiotic pre-treatment on prognostic value of CRB-65 score -Results from the German competence network CAPNETZ Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Assessment of severity and prognosis in COPD: moving beyond percent of predicted Source: Eur Respir J, 52 (2) 1801005; 10.1183/13993003.01005-2018 Year: 2018 Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Asthma diagnosis and severity assessment, can microRNAs help? A pilot study Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Translation and validation of the Quality-of-Life Bronchiectasis questionnaire in Swedish, and correlation with clinical outcomes. Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Impact of COVID-19 pneumonia on pulmonary function, radiographic imaging and quality of life in a cohort of survivors Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function Year: 2021 Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients. Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020 A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006 Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Responsiveness of 3 subjective instruments for assessment of functional status in patients with COPD Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles Year: 2008 BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017